Crossmark

Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation

Crossref DOI link: https://doi.org/10.1007/s10792-021-01806-0

Published Online: 2021-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xiang-ning

Cai, Xuan

He, Sijin

Zhang, Xueyan

Wu, Qiang https://orcid.org/0000-0002-7512-0109
Funding

Funding for this research was provided by:

College-level Project Fund of Shanghai Jiaotong University Affiliated Sixth People's Hospital (No. ynlc201723 and ynlc201909)
License Information

Text and Data Mining valid from 2021-03-30

Version of Record valid from 2021-03-30
More Information

Article History

Received: 15 November 2020

Accepted: 9 March 2021

First Online: 30 March 2021

Declarations

:

: The authors declare that they have no competing interests.

: The Declaration of Helsinki was strictly followed in all procedures. Written informed consent, which was approved by the Office of Research Ethical Committee of the Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, was obtained from all subjects. It was registered in the Chinese clinical trial registry ( number: ChiCTR-ROC-17013360).

: Written informed consent for publication was obtained from all participants.

Document is current

Any future updates will be listed below